🇺🇸 FDA
Patent

US 10517917

Compositions and methods for preventing or treating pulmonary hypertension

granted A61KA61K2236/13A61K2236/15

Quick answer

US patent 10517917 (Compositions and methods for preventing or treating pulmonary hypertension) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2236/13, A61K2236/15, A61K2236/333, A61K2236/53